Annual report pursuant to Section 13 and 15(d)

Revenue Recognition (Tables)

v3.19.1
Revenue Recognition (Tables)
12 Months Ended
Dec. 31, 2018
Revenue Recognition [Abstract]  
Schedule of revenue recognition

Revenue by Service Line

 

    Years Ended December 31,
    2018   2017
Products:                
Disposable products:                
Functional neurosurgery   $ 5,313,041     $ 5,233,092  
Biologics and drug delivery     951,940       675,809  
Capital equipment     420,039       1,115,109  
Total product revenue     6,685,020       7,024,010  
Services:                
Functional neurosurgery     100,000        
Biologics and drug delivery     175,223        
Capital equipment and other     393,023       355,515  
Total service revenue     668,246       355,515  
Total revenue   $ 7,353,266     $ 7,379,525